News for Healthier Living

Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) -- the leading cause of cancer deaths worldwide -- improved long-term survival overall compared with chemotherapy alone, according to a landmark study published June 2 in the New England Journal of Medicine.

June 3, 2025


June 14 2025

June 13 2025

June 12 2025

June 11 2025

June 10 2025

June 9 2025

June 8 2025

June 7 2025

June 6 2025

June 5 2025

June 4 2025

June 3 2025

June 2 2025

June 1 2025